Weekly Newsletter - Week of July 22nd, 2024
Information Mediary Corp. (IMC)
We build tools and technologies to provide medication adherence insights, cold chain and smart drug logistics
Smart packaging offers a practical solution by ensuring data genuinely reflects patient behavior. As clinical research evolves, integrating smart packaging could become as fundamental as blinding and randomization.
Over the past two decades, clinical trials have witnessed a remarkable evolution with increased decentralization and the integration of advanced technologies.?
In recent years, the complexity of clinical trials has surged dramatically, introducing new challenges for clinical operations (ClinOps) teams. Trials now involve more regions — with Phase 3 trials seeing a 39% increase?in countries since 2015 — more investigator sites and more protocol amendments.
As technology evolves and it becomes easier to collect data, the question is now if data collection has tipped too far. The number of data points being collected by sponsors has increased dramatically over the past decade, with research conducted by Duke-Margolis Health Policy Center showing there has been a 283.2% increase in data points collected during Phase III trials.
Last month, Accenture published a report?titled “Reinventing R&D in the age of AI,” outlining how biopharmaceutical companies have been and can continue to leverage artificial intelligence (AI) and other intelligent technologies in the drug and therapeutic research and development pipeline.